Iain J. Mulford

Targeting FGFR overcomes EMT-mediated resistance in EGFR mutant non-small cell lung cancer

Sana Raoof, Iain J. Mulford, Heidie Frisco Cabanos et al. · Oncogene · 2019 · 207 citations · Full text

Medicine, Epithelial-mesenchymal Interactions, Bronchial Neoplasm +8

The potent and selective cyclin-dependent kinases 4 and 6 inhibitor ribociclib (LEE011) is a versatile combination partner in preclinical cancer models

Sunkyu Kim, Ralph Tiedt, Alice Loo et al. · Oncotarget · 2018 · 88 citations · Full text

Inhibition of MDM2 Promotes Antitumor Responses in p53 Wild-Type Cancer Cells through Their Interaction with the Immune and Stromal Microenvironment

Hui Qin Wang, Iain J. Mulford, Fiona A. Sharp et al. · Cancer Research · 2021 · 59 citations · Full text

Inducible expression of TGFβ, Snail and Zeb1 recapitulates EMT in vitro and in vivo in a NSCLC model

Gretchen Argast, Joseph S. Krueger, Stuart Thomson et al. · Clinical & Experimental Metastasis · 2011 · 58 citations

Nsclc Model, Developmental Biology, Signal Transduction +9

Cooperative Signaling between Oncostatin M, Hepatocyte Growth Factor and Transforming Growth Factor-β Enhances Epithelial to Mesenchymal Transition in Lung and Pancreatic Tumor Models

Gretchen Argast, Peter Mercado, Iain J. Mulford et al. · Cells Tissues Organs · 2010 · 28 citations

Pathology, Cell Proliferation, Emt States +17